Mandate

Vinge has advised Priveq Investment in connection with the investment in ROL

Today ROL offers workspace solutions including software and ergonomically optimized office furniture and store concept solutions. ROL’s offering is sold globally both through ROL’s own sales organization and distributors. In 2020, ROL had a turnover of approximately SEK 1.6 billion and 890 employees in ten different countries.

The Hjelm family has partnered with Priveq Investment as a new minority owner to support the company in its accelerated growth strategy. The Hjelm family will continue as majority owners in ROL, with Arne Karlsson continuing as the Chairman of the Board.

Vinge’s team consisted of Jonas Johansson, Karl Klackenberg and Jesper Lindvall (M&A), together with Kristoffer Larson (Real Estate), Johan Cederblad and Lina Österberg (Environment), Jolene Reimerson and Mathilda Persson (IT, Agreements and GDPR), Sofia Bergenstråhle (IP), Karl-Gustaw Tobola (Financing), Ebba Svenburg (Employment), Carl Bruneheim and Viktoria Owetz Leyva (VDR).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026